Nurse Practitioner in Moore Haven, FL Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Juslain Jonathas, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1021 Health Park Dr, Moore Haven, FL 33471 Phone: 863-946-0405 Fax: 863-847-2310 |
Harry Jean, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1021 Health Park Dr, Moore Haven, FL 33471 Phone: 863-946-0405 |
 Gloria Rodriguez Rodriguez, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1021 Health Park Dr, Moore Haven, FL 33471 Phone: 863-946-0405 Fax: 844-542-8959 |
Jennifer Nichole Johnson, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 43 Avenue J Sw, Moore Haven, FL 33471 Phone: 863-599-1620 |
News Archive
How to avoid MRSA infection
Staph bacteria are not uncommon in health care settings. In fact, they account for a large number of hospital-related infections each year.
Researchers to use three-dimensional liver mimic for toxicity study on human body
The liver is the primary organ in the human body that metabolizes foreign compounds such as drugs, alcohol, cigarette smoke, and environmental chemicals. Using the liver as an alarm system, researchers are starting to better understand the different levels of toxicity from these compounds and their effects on the human body.
Growing up in polluted towns and cities increases risk of lung health issues
Children who grow up in towns and cities with high pollution levels are at increased risk of lung health issues or low functioning lungs. New research suggests that pollutants from vehicle emissions and fossil fuels have an adverse effect on a child's lung development and can also lower childrens lifetime breathing capacity.
Abeona Therapeutics obtains FDA Orphan Drug Designations for Sanfilippo Syndrome therapies
Abeona Therapeutics, a start-up company created around intellectual property licensed from Nationwide Children's Hospital to develop treatments for Sanfilippo Syndrome Types A and B, has been granted Orphan Drug Designations for its lead investigational therapies by the U.S. Food and Drug Administration Office of Orphan Products Development.
› Verified 5 days ago